ANVS: Annovis Bio, Inc. Stock

by  •  • Comments Off on ANVS: Annovis Bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 29.23
Enterprise Value ($M) 18.68
Book Value ($M) 9.31
Book Value / Share 0.48
Price / Book 3.14
NCAV ($M) 9.31
NCAV / Share 0.48
Price / NCAV 3.14

Profitability (mra)
Return on Invested Capital (ROIC) -2.64
Return on Assets (ROA) -3.15
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 3.59
Current Ratio 3.59

Balance Sheet (mrq) ($M)
Current Assets 13.93
Assets 13.93
Liabilities 4.62
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -26.69
Net Income -24.59
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -21.89
Cash from Investing 0.00
Cash from Financing 26.69

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-10 13G CVI Investments, Inc. 5.10

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-01 83,360 209,055 39.87
2025-03-31 135,011 342,644 39.40
2025-03-28 100,994 379,942 26.58
2025-03-27 63,287 163,191 38.78

(click for more detail)

Similar Companies
ABT – Abbott Laboratories ADCT – ADC Therapeutics SA
ANRO – Alto Neuroscience, Inc. BHC – Bausch Health Companies Inc.
BHVN – Biohaven Ltd.


Financial data and stock pages provided by
Fintel.io